Home › Cases › Mild Bronchiolitis — Safe Discharge
Bronchiolitis
Mild Bronchiolitis — Safe Discharge
6 questions
Question 1 · Assessment
Correct answer: Mild — can be managed at home with safety-netting
Why
Mild bronchiolitis: SpO₂ ≥95%, feeding >75%, no apnoeas, mild or no recession — safe for discharge with clear safety-netting advice per NICE NG9.
Key point
Mild: SpO₂ ≥95%, feeding >75%, no apnoeas. Safe for home with safety-netting.
Question 2 · What Not to Prescribe
Correct answer: Salbutamol, steroids, and antibiotics have no evidence in bronchiolitis and are not indicated
Why
None of these are recommended: salbutamol has no benefit; steroids are harmful; antibiotics are for bacterial infection only. NICE NG9 is clear.
Key point
No salbutamol, no steroids, no antibiotics, no chest physio in bronchiolitis. Supportive care only.
Question 3 · Feeding Advice
Correct answer: Smaller, more frequent feeds (breast or bottle). Saline nasal drops before feeds may help. Return if intake drops below 50–75%
Why
Smaller, frequent feeds are recommended as nasal congestion makes prolonged feeding difficult.
- Saline nasal drops help clear congestion before feeds
- No need to stop breastfeeding — breast milk is protective
- Return if feeds drop below 50%
Key point
Smaller frequent feeds. Saline nasal drops help. Do not stop breastfeeding. Return if feeds drop below 50%.
Question 4 · Safety-Netting
Correct answer: Return if apnoeas, feeding <50%, increased breathing difficulty, or parents concerned
Why
Safety-netting for bronchiolitis:
- Apnoeas (pauses in breathing)
- Feeding <50%
- Significantly increased work of breathing
- Parental concern
- Colour change (pale/blue)
Apnoeas especially in young infants are red flag.
Key point
Return for apnoeas, feeding <50%, worsening breathing, cyanosis, or parental concern.
Question 5 · Duration of Illness
Correct answer: Typical illness: worst at days 3–5, cough can persist for up to 3 weeks
Why
Bronchiolitis is typically worst at days 3–5, improves gradually, but cough may persist 3 weeks. Setting appropriate expectations prevents unnecessary re-attendances.
Key point
Worst at days 3–5. Cough may persist 3 weeks. Set expectations to reduce unnecessary re-attendance.
Question 6 · Prevention
Correct answer: Palivizumab (monthly IM) is offered to high-risk infants (ex-prems, CHD, CLD) in RSV season
Why
Palivizumab is monoclonal antibody against RSV offered monthly Oct–March to high-risk infants:
- Ex-premature
- CHD
- CLD
Reduces but doesn't eliminate bronchiolitis risk. RSV maternal vaccine (Abrysvo) approved in 2024.
Key point
Palivizumab monthly Oct–March for high-risk infants (ex-prem, CHD, CLD). RSV maternal vaccine now available.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.